686 related articles for article (PubMed ID: 30292337)
41. Predictors of outcomes of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with chronic kidney disease.
Kim JH; Yang JH; Choi SH; Song YB; Hahn JY; Choi JH; Lee SH; Gwon HC
Am J Cardiol; 2014 Dec; 114(12):1830-5. PubMed ID: 25438909
[TBL] [Abstract][Full Text] [Related]
42. Remote ischemic preconditioning for prevention of contrast induced nephropathy-Insights from an Indian study.
Valappil SP; Kunjukrishnapillai S; Viswanathan S; Koshy AG; Gupta PN; Velayudhan RV; Iype M
Indian Heart J; 2018; 70(6):857-863. PubMed ID: 30580857
[TBL] [Abstract][Full Text] [Related]
43. CHADS2 score predicts risk of contrast-induced nephropathy in stable coronary artery disease patients undergoing percutaneous coronary interventions.
Chou RH; Huang PH; Hsu CY; Leu HB; Huang SS; Huang CC; Chen JW; Lin SJ
J Formos Med Assoc; 2016 Jul; 115(7):501-9. PubMed ID: 26830105
[TBL] [Abstract][Full Text] [Related]
44. Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy] trial.
Patti G; Ricottini E; Nusca A; Colonna G; Pasceri V; D'Ambrosio A; Montinaro A; Di Sciascio G
Am J Cardiol; 2011 Jul; 108(1):1-7. PubMed ID: 21529740
[TBL] [Abstract][Full Text] [Related]
45. Relation of uric acid and contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention in the ED.
Saritemur M; Turkeli M; Kalkan K; Tanboga İH; Aksakal E
Am J Emerg Med; 2014 Feb; 32(2):119-23. PubMed ID: 24238488
[TBL] [Abstract][Full Text] [Related]
46. Impact of concomitant treatment of non-chronic total occlusion lesions at the time of chronic total occlusion intervention.
Xenogiannis I; Karmpaliotis D; Alaswad K; Jaffer FA; Yeh RW; Patel M; Mahmud E; Choi JW; Burke MN; Doing AH; Dattilo P; Toma C; Uretsky B; Krestyaninov O; Khelimskii D; Holper E; Potluri S; Wyman RM; Kandzari DE; Garcia S; Koutouzis M; Tsiafoutis I; Khatri JJ; Jaber W; Samady H; Jefferson BK; Patel T; Moses JW; Lembo NJ; Parikh M; Kirtane AJ; Ali ZA; Gkargkoulas F; Tajti P; Hall AB; Rangan BV; Abdullah S; Banerjee S; Brilakis ES
Int J Cardiol; 2020 Jan; 299():75-80. PubMed ID: 31301862
[TBL] [Abstract][Full Text] [Related]
47. Procedural outcomes of chronic total occlusion percutaneous coronary intervention: a report from the NCDR (National Cardiovascular Data Registry).
Brilakis ES; Banerjee S; Karmpaliotis D; Lombardi WL; Tsai TT; Shunk KA; Kennedy KF; Spertus JA; Holmes DR; Grantham JA
JACC Cardiovasc Interv; 2015 Feb; 8(2):245-253. PubMed ID: 25700746
[TBL] [Abstract][Full Text] [Related]
48. Risk factors and clinical outcomes for contrast-induced nephropathy after percutaneous coronary intervention in patients with normal serum creatinine.
Chong E; Poh KK; Liang S; Tan HC
Ann Acad Med Singap; 2010 May; 39(5):374-80. PubMed ID: 20535427
[TBL] [Abstract][Full Text] [Related]
49. Relationship between red cell distribution width and contrast-induced nephropathy in patients who underwent primary percutaneous coronary intervention.
Akkoyun DÇ; Akyüz A; Kurt Ö; Bilir B; Alpsoy Ş; Güler N
Turk Kardiyol Dern Ars; 2015 Oct; 43(7):613-20. PubMed ID: 26536986
[TBL] [Abstract][Full Text] [Related]
50. Initial success rate of percutaneous coronary intervention for chronic total occlusion in a native coronary artery is decreased in patients who underwent previous coronary artery bypass graft surgery.
Teramoto T; Tsuchikane E; Matsuo H; Suzuki Y; Ito T; Ito T; Habara M; Nasu K; Kimura M; Kinoshita Y; Terashima M; Asakura Y; Matsubara T; Suzuki T
JACC Cardiovasc Interv; 2014 Jan; 7(1):39-46. PubMed ID: 24456717
[TBL] [Abstract][Full Text] [Related]
51. Procedural and In-Hospital Outcomes of Chronic Total Occlusion Percutaneous Coronary Interventions in Patients With Acute Myocardial Infarction: Insights From a Prospective Multicenter International Registry.
Arman P; Basir MB; Gupta A; Choi JW; Khatri JJ; Jaffer FA; Poomipanit P; Forouzandeh F; Koutouzis M; Tsiafoutis I; Patel M; Mahmud E; Vemmou E; Nikolakopoulos I; Karacsonyi J; ElGuindy A; Goktekin O; Abi Rafeh N; Brilakis ES; Alaswad K
J Invasive Cardiol; 2021 Sep; 33(9):E670-E676. PubMed ID: 34473071
[TBL] [Abstract][Full Text] [Related]
52. Impact of metabolic syndrome on development of contrast-induced nephropathy after elective percutaneous coronary intervention among nondiabetic patients.
Ozcan OU; Adanir Er H; Gulec S; Ustun EE; Gerede DM; Goksuluk H; Tulunay Kaya C; Erol C
Clin Cardiol; 2015 Mar; 38(3):150-6. PubMed ID: 25800136
[TBL] [Abstract][Full Text] [Related]
53. Left ventricular end diastolic pressure and contrast-induced acute kidney injury in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Lima FV; Singh S; Parikh PB; Gruberg L
Cardiovasc Revasc Med; 2018 Sep; 19(6S):16-20. PubMed ID: 29929842
[TBL] [Abstract][Full Text] [Related]
54. Prognostic value of the age, creatinine, and ejection fraction score for non-infarct-related chronic total occlusion revascularization after primary percutaneous intervention in acute ST-elevation myocardial infarction patients: A retrospective study.
Deng J; Wang X; Shi Y; Zhao X; Han Y
J Interv Cardiol; 2018 Feb; 31(1):33-40. PubMed ID: 28940388
[TBL] [Abstract][Full Text] [Related]
55. Frequency and risk factors of contrast-induced nephropathy after cardiac catheterization in type II diabetic patients: a study among Egyptian patients.
Sany D; Refaat H; Elshahawy Y; Mohab A; Ezzat H
Ren Fail; 2014 Mar; 36(2):191-7. PubMed ID: 24138570
[TBL] [Abstract][Full Text] [Related]
56. Impact of target vessel on long-term cardiac mortality after successful chronic total occlusion percutaneous coronary intervention: Insights from a Japanese multicenter registry.
Mitomo S; Naganuma T; Jabbour RJ; Sato K; Takebayashi H; Kobayashi T; Obata JE; Sakamoto K; Tsujita K; Kugiyama K; Ogawa H; Nakamura S
Int J Cardiol; 2017 Oct; 245():77-82. PubMed ID: 28789842
[TBL] [Abstract][Full Text] [Related]
57. Prediction of contrast-induced nephropathy in diabetics undergoing elective percutaneous coronary intervention: role of the ratio of contrast medium volume to estimated glomerular filtration rate.
Wang XC; Fu XH; Wang YB; Jia XW; Wu WL; Gu XS; Zhang J; Su JL; Hao GZ; Jiang YF; Fan WZ; Li SQ
Chin Med J (Engl); 2011 Mar; 124(6):892-6. PubMed ID: 21518598
[TBL] [Abstract][Full Text] [Related]
58. The predictive value of the renal resistive index for contrast-induced nephropathy in patients with acute coronary syndrome.
Xu ZR; Chen J; Liu YH; Liu Y; Tan N
BMC Cardiovasc Disord; 2019 Feb; 19(1):36. PubMed ID: 30744553
[TBL] [Abstract][Full Text] [Related]
59. Contrast volume to creatinine clearance ratio for the prediction of contrast-induced nephropathy in patients undergoing coronary angiography or percutaneous intervention.
Barbieri L; Verdoia M; Marino P; Suryapranata H; De Luca G;
Eur J Prev Cardiol; 2016 Jun; 23(9):931-7. PubMed ID: 26525064
[TBL] [Abstract][Full Text] [Related]
60. Safety and efficacy of anisodamine on prevention of contrast induced nephropathy in patients with acute coronary syndrome.
Wang YB; Fu XH; Gu XS; Wang XC; Zhao YJ; Hao GZ; Jiang YF; Fan WZ; Wu WL; Li SQ; Xue L
Chin Med J (Engl); 2012 Mar; 125(6):1063-7. PubMed ID: 22613532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
